세계의 실험실 자동화 시장 : 제품별, 용도별, 최종 사용자별, 지역별 - 예측(-2029년)

The global lab automation market is projected to reach USD 7.71 Billion by 2029 from USD 5.85 Billion in 2024, growing at a CAGR of 6.9% during the forecast period. Some of the primary drivers for the lab automation solutions include the need for high-throughput testing, an increase in omics research, and the need for more precise and faster results in laboratory procedures. Moreover, an increase in the prevalence of chronic diseases necessitates expenditure in research and development and need for faster diagnosis, which increases the adoption of automation.

"Automated Workstation to register largest market share in 2023"

The automated workstation segment will lead the lab automation market during the forecast period. This product line helps optimize the laboratory workflow through streamlined workstations, and increased precision, and reproducibility across many applications. In the case of the automated workstation product, liquid-handling workstation products are currently most commonly used for high-accuracy transfer of samples and reagents that are vital in a variety of applications involving PCR, qPCR, next-generation sequencing, etc. Another major sub-segment is microplate readers. It enables high-throughput screening and quantification in assays, thus significantly speeding up drug discovery and biological research. Automated ELISA systems are in high demand because they automate the protocols that take time to run through immunoassays. Automated ELISA systems save diagnostics and clinical laboratories lots of time because it does all the immunoassay protocols, hence the output is rapid and reliable, minimizing the involvement of manual inputs. Apart from that, automated nucleic acid purification systems are considered necessary for molecular biology and genomics research to speed up DNA and RNA extraction and purification processes for further applications. Growth in these sub-segments is indicative of the interest of the lab automation market toward increasing efficiency and data quality, which are now crucial factors in all pharmaceutical, diagnostic, and research settings.

"Hospitals & diagnostic laboratories segment held the largest share of Lab Automation market in 2023, by End-user."

The market by end-users of the lab automation market is further divided into hospitals and diagnostic laboratories, pharmaceutical and biotechnology companies, research and academic institutes, environmental testing laboratories, forensic laboratories, and the food and beverage industry. The largest share in 2023 would be hospitals and diagnostic laboratories mainly due to increasing demand for throughput, accuracy, and high-speed diagnostics solutions to treat more patients requiring a variety of complex tests. This will ensure automation solutions simplify workflows, minimize turnaround times, and improve accuracy.

"Asia Pacific to register highest growth rate in the market during the forecast period."

The Asia Pacific region will be the leader in growth in the lab automation market, with the highest rate during the forecast period. It will be driven by increased investment in healthcare infrastructure, research and development emphasis by the pharmaceutical and biotechnology industries, and increased demand for efficient diagnostic solutions for this region's increasing population. In addition, developments in artificial intelligence and robotics are assisting the laboratories within other sectors to become more automated.

A breakdown of the primary participants referred to for this report is provided below:

• By Company Type: Tier 1-30%, Tier 2-42%, and Tier 3- 28%
• By Designation: C-level-- 10%, Director-level-14%, and Others-76%
• By Region: North America-40%, Europe-30%, Asia Pacific-22%, Rest of the world-8%

Prominent players in the Lab Automation market include: Thermo Fisher Scientific (US), Tecan Group (Switzerland), Danaher Corporation (US), Agilent Technologies (US), F. Hoffmann-La Roche Ltd. (Switzerland), Revvity (US), Eppendorf AG (Germany), Becton, Dickinson and Company (US), Waters Corporation (US), Siemens Healthineers (Germany), Abbott Laboratories (US), Biomerieux (France), Hamilton Company (US), Hudson Robotics (US) .

Research Coverage

The market is categorized by the product, application, end-user, and region. Factors affecting the lab automation market-including drivers, restraints, opportunities, and challenges are also discussed in the report. The report provides a perspective of opportunities and challenges ahead for stakeholders, besides profiling the details of leading players' competitive landscape. The micro-markets are further segregated by focusing on growth trends, prospects, and contributions of these trends to the lab automation market. To this, revenue generation through different market segments shall be forecasted and their respective growth focus put together based on five major geographies.

Key Benefits of Buying this Report

This report is to be benefitted by new and existing players. It will give deep information about the lab automation market for them to understand any investment opportunities. The present report provides complete information on the key players and minor players. Hence, this supports effective risk analysis along with informed decisions about investment. Owing to the accurate segmentation based on end-users and geographies, this report gives niche-level views of the selected market areas. Further, this report supplies critical trends, challenges, growth drivers, and opportunities that complete the strategic decision-making process with a well-balanced analysis.

Through this report, readers get insightful views into the following parameters:

Analysis of the key growth drivers, restraints, challenges, and opportunities influencing market growth for lab automation market. The major driving forces behind lab automation market are an increase in chronic diseases. Requirement for rapid and precise diagnostic tools enhances demand for automation solutions. Technologically, the development of rapid and automated testing systems supports market growth by increasing efficiency and accuracy in tests.

Product Development/Innovation: Emerging technologies, ongoing R&D activities, and recent launches of products and services in the antimicrobial susceptibility testing market.

Market Development: Further, the report has elaborated the markets by segmenting the lab automation market into different regions

Market Diversification: New product launches, unexploited markets, recent developments, investments in the lab automation market.

Competitive Analysis: Exhaustive study of market share, service offering leading strategies of major players such as Thermo Fisher Scientific (US), Tecan Group (Switzerland), Danaher Corporation (US), Agilent Technologies (US), F. Hoffmann-La Roche Ltd. (Switzerland), Revvity (US), Eppendorf AG (Germany), Becton, Dickinson and Company (US), Waters Corporation (US), Siemens Healthineers (Germany), Abbott Laboratories (US), Biomerieux (France), Hamilton Company (US), Hudson Robotics (US) .

TABLE OF CONTENTS

1 INTRODUCTION

• 1.1 STUDY OBJECTIVES
• 1.2 MARKET DEFINITION
• 1.3 INCLUSIONS AND EXCLUSIONS
• 1.4 MARKET SCOPE
  • 1.4.1 MARKETS COVERED
  • 1.4.2 YEARS CONSIDERED
  • 1.4.3 CURRENCY CONSIDERED
• 1.5 MARKET STAKEHOLDERS
• 1.6 SUMMARY OF CHANGES
• 1.7 ADDITION OF IMPACT OF GENERATIVE AI

2 RESEARCH METHODOLOGY

• 2.1 RESEARCH DATA
• 2.2 RESEARCH DATA
• 2.3 RESEARCH DESIGN
  • 2.3.1 SECONDARY RESEARCH
    • 2.3.1.1 Key data from secondary sources
  • 2.3.2 PRIMARY RESEARCH
    • 2.3.2.1 Primary sources
    • 2.3.2.2 Key industry insights
• 2.4 MARKET SIZE ESTIMATION
  • 2.4.1 BOTTOM-UP APPROACH
    • 2.4.1.1 Approach 1: Company revenue estimation approach
    • 2.4.1.2 Approach 2: Customer-based market estimation
  • 2.4.2 TOP-DOWN APPROACH
    • 2.4.2.1 Approach 3: Top-down approach
    • 2.4.2.2 Approach 4: Primary interviews
• 2.5 GROWTH FORECAST
• 2.6 DATA TRIANGULATION
• 2.7 MARKET SHARE ASSESSMENT
• 2.8 RESEARCH ASSUMPTIONS
• 2.9 RESEARCH LIMITATIONS
  • 2.9.1 RISK ASSESSMENT

3 EXECUTIVE SUMMARY

4 PREMIUM INSIGHTS

• 4.1 LAB AUTOMATION MARKET OVERVIEW
• 4.2 LAB AUTOMATION MARKET, BY REGION
• 4.3 ASIA PACIFIC: LAB AUTOMATION MARKET, BY COUNTRY AND END USER
• 4.4 GEOGRAPHIC SNAPSHOT OF LAB AUTOMATION MARKET

5 MARKET OVERVIEW

• 5.1 INTRODUCTION
• 5.2 MARKET DYNAMICS
  • 5.2.1 DRIVERS
    • 5.2.1.1 Need for automation in drug discovery
    • 5.2.1.2 Advancements in artificial intelligence and robotics
    • 5.2.1.3 Growth in demand for process automation for food safety
    • 5.2.1.4 Rise in demand for automation in forensics
  • 5.2.2 RESTRAINTS
    • 5.2.2.1 High initial investment costs
    • 5.2.2.2 Slow adoption in developing regions
  • 5.2.3 OPPORTUNITIES
    • 5.2.3.1 Increased expenditure on healthcare
    • 5.2.3.2 Growth in pharmaceutical and biotechnology industries
  • 5.2.4 CHALLENGES
    • 5.2.4.1 System integration issues
    • 5.2.4.2 Availability of refurbished lab automation equipment
• 5.3 TECHNOLOGY ANALYSIS
  • 5.3.1 KEY TECHNOLOGIES
    • 5.3.1.1 Cobots
    • 5.3.1.2 Biobanking
    • 5.3.1.3 High-throughput screening (HTS) technologies
  • 5.3.2 COMPLEMENTARY TECHNOLOGIES
    • 5.3.2.1 Cloud connectivity
    • 5.3.2.2 Internet of Things (IoT)
    • 5.3.2.3 Digital twins
  • 5.3.3 ADJACENT TECHNOLOGIES
    • 5.3.3.1 MICROFLUIDICS TECHNOLOGY
• 5.4 SUPPLY CHAIN ANALYSIS
  • 5.4.1 PROMINENT COMPANIES
  • 5.4.2 SMALL AND MEDIUM-SIZED ENTERPRISES
  • 5.4.3 END USERS
• 5.5 VALUE CHAIN ANALYSIS
  • 5.5.1 RESEARCH & DEVELOPMENT
  • 5.5.2 RAW MATERIAL PROCUREMENT & MANUFACTURING
  • 5.5.3 DISTRIBUTION, MARKETING & SALES, AND POST-SALES SERVICES
• 5.6 PORTER'S FIVE FORCES ANALYSIS
  • 5.6.1 THREAT OF NEW ENTRANTS
  • 5.6.2 THREAT OF SUBSTITUTES
  • 5.6.3 BARGAINING POWER OF SUPPLIERS
  • 5.6.4 BARGAINING POWER OF BUYERS
  • 5.6.5 INTENSITY OF COMPETITIVE RIVALRY
• 5.7 KEY STAKEHOLDERS AND BUYING CRITERIA
  • 5.7.1 KEY STAKEHOLDERS IN BUYING PROCESS
  • 5.7.2 KEY BUYING CRITERIA
• 5.8 PATENT ANALYSIS
  • 5.8.1 LIST OF MAJOR PATENTS
• 5.9 KEY CONFERENCES AND EVENTS
• 5.10 TRADE DATA ANALYSIS
  • 5.10.1 IMPORT DATA (HS CODE 8479)
  • 5.10.2 EXPORT DATA (HS CODE 8479)
• 5.11 UNMET NEEDS AND KEY PAIN POINTS
• 5.12 ECOSYSTEM ANALYSIS
• 5.13 TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS
• 5.14 INVESTMENT AND FUNDING SCENARIO
• 5.15 IMPACT OF GEN AI ON LAB AUTOMATION MARKET
• 5.16 REGULATORY LANDSCAPE
  • 5.16.1 REGULATORY STANDARDS AND APPROVALS
    • 5.16.1.1 North America
      • 5.16.1.1.1 US
      • 5.16.1.1.2 Canada
    • 5.16.1.2 Europe
    • 5.16.1.3 Asia Pacific
      • 5.16.1.3.1 Japan
      • 5.16.1.3.2 China
      • 5.16.1.3.3 India
  • 5.16.2 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
• 5.17 PRICING ANALYSIS
  • 5.17.1 AVERAGE SELLING PRICE TREND, BY REGION
  • 5.17.2 AVERAGE SELLING PRICE OF ROBOTIC ARMS, BY KEY PLAYER

6 LAB AUTOMATION MARKET, BY PRODUCT

• 6.1 INTRODUCTION
• 6.2 AUTOMATED WORKSTATIONS
  • 6.2.1 AUTOMATED LIQUID HANDLING SYSTEMS
    • 6.2.1.1 Automated integrated workstations
      • 6.2.1.1.1 Preference for modular, integrated workstations over standalone systems
    • 6.2.1.2 Pipetting systems
      • 6.2.1.2.1 Substantial progress in developing accurate robotic pipetting systems
    • 6.2.1.3 Reagent dispensers
      • 6.2.1.3.1 Adoption of advanced technologies for dispensing minute volumes by prominent players
    • 6.2.1.4 Microplate washers
      • 6.2.1.4.1 Multiple customizable benefits provided by microplate washers
  • 6.2.2 MICROPLATE READERS
    • 6.2.2.1 Multi-mode microplate readers
      • 6.2.2.1.1 Filter-based readers
        • 6.2.2.1.1.1 High sensitivity and high specificity to enhance product demand
      • 6.2.2.1.2 Monochromator-based readers
        • 6.2.2.1.2.1 Greater flexibility and enhanced sensitivity among benefits
      • 6.2.2.1.3 Hybrid readers
        • 6.2.2.1.3.1 Combined benefits of filter- and monochromator-based readers such as high flexibility, sensitivity, and convenience to laboratories
    • 6.2.2.2 Single-mode microplate readers
      • 6.2.2.2.1 Fluorescence readers
        • 6.2.2.2.1.1 Integration of AI and machine learning to enhance data analysis and interpretation
      • 6.2.2.2.2 Absorbance readers
        • 6.2.2.2.2.1 Emerging trends emphasize boosting throughput through automation and integration with robotic systems
      • 6.2.2.2.3 Luminescence readers
        • 6.2.2.2.3.1 Greater sensitivity than absorbance and fluorescence readers
  • 6.2.3 AUTOMATED ELISA SYSTEMS
    • 6.2.3.1 Greater role of immunoassays in testing with increase in incidence of chronic and infectious diseases
  • 6.2.4 AUTOMATED NUCLEIC ACID PURIFICATION SYSTEMS
    • 6.2.4.1 Wide applications of automated nucleic acid extraction systems
• 6.3 OFF-THE-SHELF AUTOMATED WORK CELLS
  • 6.3.1 PRE-ANALYTICAL AUTOMATION
    • 6.3.1.1 Consistent and accurate sample preparation with efficiency, enhancing quality of subsequent analyses
  • 6.3.2 POST-ANALYTICAL AUTOMATION
    • 6.3.2.1 Automation of data processing, results verification, and sample handling after analysis to save time and minimize human errors
  • 6.3.3 TOTAL LAB AUTOMATION
    • 6.3.3.1 Despite its advantages, total lab automation remains challenging to implement in most labs
• 6.4 SOFTWARE
  • 6.4.1 LABORATORY INFORMATION MANAGEMENT SYSTEMS
    • 6.4.1.1 Minimizing human errors and consolidating access and storage of quality control data
  • 6.4.2 ELECTRONIC LABORATORY NOTEBOOKS
    • 6.4.2.1 Data security and user-friendly interface to store and use electronic records
  • 6.4.3 LABORATORY EXECUTION SYSTEMS
    • 6.4.3.1 Paperless, high-productivity environment to optimize workflows
  • 6.4.4 SCIENTIFIC DATA MANAGEMENT SYSTEMS
    • 6.4.4.1 Securely managing consolidated scientific data generated from various laboratory instruments
• 6.5 ROBOTIC SYSTEMS
  • 6.5.1 ROBOTIC ARMS
    • 6.5.1.1 Flexibility, accuracy, and enhanced to increase application of robotic arms
  • 6.5.2 TRACK ROBOTS
    • 6.5.2.1 Innovative, customizable products offered by key players to streamline workflows
  • 6.5.3 COLLABORATIVE ROBOTS
    • 6.5.3.1 Rapidly expanding robotics technology with significant market potential
  • 6.5.4 MOBILE ROBOTS
    • 6.5.4.1 Significant technological trends and integration with software to minimize manual handling
• 6.6 AUTOMATED STORAGE & RETRIEVAL SYSTEMS
  • 6.6.1 EFFICIENT COLLECTION AND HANDLING OF CHEMICALS AND BIOLOGICS ESSENTIAL IN DRUG DISCOVERY
• 6.7 OTHER LAB AUTOMATION EQUIPMENT

7 LAB AUTOMATION MARKET, BY APPLICATION

• 7.1 INTRODUCTION
• 7.2 DRUG DISCOVERY
  • 7.2.1 ACCELERATION OF DRUG DEVELOPMENT TIMELINE THROUGH FULLY AUTOMATED, ULTRA-HIGH-THROUGHPUT SYSTEMS
  • 7.2.2 HIGH-THROUGHPUT SCREENING
    • 7.2.2.1 Integrating automation technologies with high-throughput screening to rapidly identify compounds
  • 7.2.3 COMPOUND MANAGEMENT
    • 7.2.3.1 Prominent players offering automated compound management systems that support growth
  • 7.2.4 ADME SCREENING
    • 7.2.4.1 Growth in requirement for ADME screening in drug discovery
  • 7.2.5 COMPOUND WEIGHING & DISSOLUTION
    • 7.2.5.1 Potential of automation to improve precision and operational efficiency without user intervention
  • 7.2.6 OTHER DRUG DISCOVERY APPLICATIONS
• 7.3 DIAGNOSTICS
  • 7.3.1 RISE IN IMPORTANCE OF AUTOMATION IN DIAGNOSTIC PRECISION AND EFFICIENCY
  • 7.3.2 PRE-ANALYTICS/SAMPLE PREPARATION
    • 7.3.2.1 Minimizing errors and labor costs while enhancing precision and productivity
  • 7.3.3 ENZYME IMMUNOASSAYS
    • 7.3.3.1 Rise in demand for automation of critical EIA processes with growing global burden of target diseases
  • 7.3.4 SAMPLE DISTRIBUTION, SPLITTING, AND ARCHIVING
    • 7.3.4.1 Ease of monitoring interaction and need for reduced tube manipulation
• 7.4 GENOMICS
  • 7.4.1 ANALYSIS OF HIGHER VOLUME OF VITAL DATA WITH ADVANCEMENTS IN NEXT-GENERATION SEQUENCING
• 7.5 PROTEOMICS
  • 7.5.1 NEED FOR ROBOTICS TO REDUCE COMPLEXITY OF PROTEOME DATASETS
• 7.6 MICROBIOLOGY
  • 7.6.1 INCREASE IN PRECISION AND EFFICIENCY SUPPORT DEMAND FOR AUTOMATION IN MICROBIOLOGY WORKFLOWS
• 7.7 OTHER APPLICATIONS

8 LAB AUTOMATION MARKET, BY END USER

• 8.1 INTRODUCTION
• 8.2 BIOTECHNOLOGY & PHARMACEUTICAL COMPANIES
  • 8.2.1 BIOTECH & PHARMA COMPANIES: MAJOR END USERS OF AUTOMATION
• 8.3 HOSPITAL & DIAGNOSTIC LABORATORIES
  • 8.3.1 AUTOMATION TO MEET DEMAND FOR FAST AND PRECISE RESULTS IN HOSPITALS & DIAGNOSTICS
• 8.4 RESEARCH & ACADEMIC INSTITUTES
  • 8.4.1 INCREASE IN BIOTECHNOLOGY AND LIFE SCIENCE RESEARCH
• 8.5 ENVIRONMENTAL TESTING LABORATORIES
  • 8.5.1 INTEGRATING AUTOMATION IN LABS TO ENHANCE EFFICIENCY OF SAMPLE PROCESSING, PREPARATION, AND TESTING
• 8.6 FORENSIC LABORATORIES
  • 8.6.1 PROMINENT COMPANIES TO ADOPT AUTOMATION FOR BETTER OUTCOMES WITH SUPPORT EVIDENCE ANALYSIS AND ENABLE INNOVATIVE FORENSIC TECHNIQUES
• 8.7 FOOD & BEVERAGE INDUSTRY
  • 8.7.1 INCREASE IN UTILIZATION OF ROBOTIC ARMS IN FOOD & BEVERAGE INDUSTRY

9 LAB AUTOMATION MARKET, BY REGION

• 9.1 INTRODUCTION
• 9.2 NORTH AMERICA
  • 9.2.1 NORTH AMERICA: MACROECONOMIC OUTLOOK
  • 9.2.2 US
    • 9.2.2.1 Availability of research funding and increasing pace of metabolomics research
  • 9.2.3 CANADA
    • 9.2.3.1 Innovative products related to automation with increase in focus and presence of key players
• 9.3 EUROPE
  • 9.3.1 EUROPE: MACROECONOMIC OUTLOOK
  • 9.3.2 GERMANY
    • 9.3.2.1 Presence of public & private organizations with focus on R&D
  • 9.3.3 FRANCE
    • 9.3.3.1 Rise in investments by pharma and biotech companies in R&D infrastructure and genomic research aimed at personalized therapeutics
  • 9.3.4 UK
    • 9.3.4.1 Early-stage research in new drugs and vaccines, with increased government funding in healthcare
  • 9.3.5 ITALY
    • 9.3.5.1 Biotechnology advancements and R&D investments drive market growth
  • 9.3.6 SWITZERLAND
    • 9.3.6.1 Strong player in precision manufacturing and industry 4.0
  • 9.3.7 NETHERLANDS
    • 9.3.7.1 Leader in R&D for lab automation solutions with various funding sources
  • 9.3.8 REST OF EUROPE
• 9.4 ASIA PACIFIC
  • 9.4.1 ASIA PACIFIC: MACROECONOMIC OUTLOOK
  • 9.4.2 CHINA
    • 9.4.2.1 Advanced automation solutions brought by key players
  • 9.4.3 JAPAN
    • 9.4.3.1 Strategic partnerships and expansions, with focus on healthcare of older people
  • 9.4.4 INDIA
    • 9.4.4.1 Automation technology gaining traction in Indian clinics and hospitals
  • 9.4.5 AUSTRALIA
    • 9.4.5.1 Increase in spending on healthcare and genomic research
  • 9.4.6 SOUTH KOREA
    • 9.4.6.1 Application of automation in microbiology and food & beverage sector
  • 9.4.7 REST OF ASIA PACIFIC
• 9.5 LATIN AMERICA
  • 9.5.1 LATIN AMERICA: MACROECONOMIC OUTLOOK
  • 9.5.2 BRAZIL
    • 9.5.2.1 Rise in public and private initiatives and support for scientific research
  • 9.5.3 MEXICO
    • 9.5.3.1 Favorable business environment for market players
  • 9.5.4 REST OF LATIN AMERICA
• 9.6 MIDDLE EAST & AFRICA
  • 9.6.1 MIDDLE EAST & AFRICA: MACROECONOMIC OUTLOOK
  • 9.6.2 GCC COUNTRIES
    • 9.6.2.1 Advancements in healthcare infrastructure and innovation
  • 9.6.3 REST OF MIDDLE EAST & AFRICA

10 COMPETITIVE LANDSCAPE

• 10.1 OVERVIEW
• 10.2 KEY PLAYER STRATEGY/RIGHT TO WIN
• 10.3 REVENUE ANALYSIS, 2020-2023
• 10.4 MARKET SHARE ANALYSIS, 2023
  • 10.4.1 RANKING OF KEY MARKET PLAYERS
• 10.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2023
  • 10.5.1 STARS
  • 10.5.2 EMERGING LEADERS
  • 10.5.3 PERVASIVE PLAYERS
  • 10.5.4 PARTICIPANTS
  • 10.5.5 COMPANY FOOTPRINT: KEY PLAYERS, 2023
    • 10.5.5.1 Company footprint
    • 10.5.5.2 Product footprint
    • 10.5.5.3 Application footprint
    • 10.5.5.4 End user footprint
    • 10.5.5.5 Region footprint
• 10.6 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2023
  • 10.6.1 PROGRESSIVE COMPANIES
  • 10.6.2 RESPONSIVE COMPANIES
  • 10.6.3 DYNAMIC COMPANIES
  • 10.6.4 STARTING BLOCKS
  • 10.6.5 COMPANY BENCHMARKING: STARTUPS/SMES, 2023
    • 10.6.5.1 Detailed list of key startup/Sme players, 2023
    • 10.6.5.2 Competitive benchmarking of key emerging players/startups
• 10.7 COMPANY VALUATION AND FINANCIAL METRICS
• 10.8 PRODUCT/BRAND COMPARISON
• 10.9 COMPETITIVE SCENARIO
  • 10.9.1 PRODUCT LAUNCHES AND APPROVALS
  • 10.9.2 DEALS
  • 10.9.3 EXPANSION

11 COMPANY PROFILES

• 11.1 KEY PLAYERS
  • 11.1.1 THERMO FISHER SCIENTIFIC INC.
    • 11.1.1.1 Business overview
    • 11.1.1.2 Products offered
    • 11.1.1.3 Recent developments
      • 11.1.1.3.1 Product launches and approvals
      • 11.1.1.3.2 Deals
      • 11.1.1.3.3 Expansions
    • 11.1.1.4 MnM view
      • 11.1.1.4.1 Right to win
      • 11.1.1.4.2 Strategic choices
      • 11.1.1.4.3 Weaknesses and competitive threats
  • 11.1.2 TECAN TRADING AG
    • 11.1.2.1 Business overview
    • 11.1.2.2 Products offered
    • 11.1.2.3 Recent developments
      • 11.1.2.3.1 Product launches
      • 11.1.2.3.2 Deals
    • 11.1.2.4 MnM view
      • 11.1.2.4.1 Right to win
      • 11.1.2.4.2 Strategic choices
      • 11.1.2.4.3 Weaknesses and competitive threats
  • 11.1.3 DANAHER CORPORATION
    • 11.1.3.1 Business overview
    • 11.1.3.2 Products offered
    • 11.1.3.3 Recent developments
      • 11.1.3.3.1 Deals
    • 11.1.3.4 MnM view
      • 11.1.3.4.1 Right to win
      • 11.1.3.4.2 Strategic choices
      • 11.1.3.4.3 Weaknesses and competitive threats
  • 11.1.4 AGILENT TECHNOLOGIES
    • 11.1.4.1 Business overview
    • 11.1.4.2 Products offered
    • 11.1.4.3 Recent developments
      • 11.1.4.3.1 Product launches
      • 11.1.4.3.2 Deals
      • 11.1.4.3.3 Expansions
    • 11.1.4.4 MnM view
      • 11.1.4.4.1 Right to win
      • 11.1.4.4.2 Strategic choices
      • 11.1.4.4.3 Weaknesses and competitive threats
  • 11.1.5 F. HOFFMANN-LA ROCHE LTD.
    • 11.1.5.1 Business overview
    • 11.1.5.2 Products offered
    • 11.1.5.3 Recent developments
      • 11.1.5.3.1 Product launches
      • 11.1.5.3.2 Deals
      • 11.1.5.3.3 Expansions
    • 11.1.5.4 MnM view
      • 11.1.5.4.1 Right to win
      • 11.1.5.4.2 Strategic choices
      • 11.1.5.4.3 Weaknesses and competitive threats
  • 11.1.6 METTLER TOLEDO
    • 11.1.6.1 Business overview
    • 11.1.6.2 Products offered
    • 11.1.6.3 Recent developments
      • 11.1.6.3.1 Product launches
      • 11.1.6.3.2 Deals
  • 11.1.7 REVVITY, INC.
    • 11.1.7.1 Business overview
    • 11.1.7.2 Products offered
    • 11.1.7.3 Recent developments
      • 11.1.7.3.1 Product launches
      • 11.1.7.3.2 Deals
  • 11.1.8 EPPENDORF SE
    • 11.1.8.1 Business overview
    • 11.1.8.2 Products offered
    • 11.1.8.3 Recent developments
      • 11.1.8.3.1 Product launches
      • 11.1.8.3.2 Deals
  • 11.1.9 BECTON, DICKINSON AND COMPANY
    • 11.1.9.1 Business overview
    • 11.1.9.2 Products offered
    • 11.1.9.3 Recent developments
      • 11.1.9.3.1 Product launches and approval
      • 11.1.9.3.2 Deals
      • 11.1.9.3.3 Expansions
  • 11.1.10 WATERS CORPORATION
    • 11.1.10.1 Business overview
    • 11.1.10.2 Products offered
    • 11.1.10.3 Recent developments
      • 11.1.10.3.1 Deals
      • 11.1.10.3.2 Expansions
  • 11.1.11 SIEMENS HEALTHINEERS
    • 11.1.11.1 Business overview
    • 11.1.11.2 Products offered
    • 11.1.11.3 Recent developments
      • 11.1.11.3.1 Product launches
      • 11.1.11.3.2 Expansions
  • 11.1.12 ABBOTT LABORATORIES
    • 11.1.12.1 Business overview
    • 11.1.12.2 Products offered
  • 11.1.13 BIOMERIEUX
    • 11.1.13.1 Business overview
    • 11.1.13.2 Products offered
  • 11.1.14 HAMILTON COMPANY
    • 11.1.14.1 Business overview
    • 11.1.14.2 Products offered
    • 11.1.14.3 Recent developments
      • 11.1.14.3.1 Product launches
      • 11.1.14.3.2 Deals
  • 11.1.15 HUDSON ROBOTICS
    • 11.1.15.1 Business overview
    • 11.1.15.2 Products offered
    • 11.1.15.3 Recent developments
      • 11.1.15.3.1 Deals
• 11.2 OTHER COMPANIES
  • 11.2.1 GILSON, INC.
  • 11.2.2 BMG LABTECH
  • 11.2.3 FESTO AG & CO. KG
  • 11.2.4 AURORA BIOMED INC.
  • 11.2.5 HIGHRES BIOSOLUTIONS
  • 11.2.6 OPENTRONS LABWORKS INC.
  • 11.2.7 PEAK ANALYSIS AND AUTOMATION
  • 11.2.8 QIAGEN N.V.
  • 11.2.9 LABVANTAGE SOLUTIONS, INC.
  • 11.2.10 BIO-RAD LABORATORIES, INC.
  • 11.2.11 LABWARE
  • 11.2.12 SYSMEX CORPORATION
  • 11.2.13 UNIVERSAL ROBOTS
  • 11.2.14 AB CONTROLS, INC.
  • 11.2.15 AUTOMATA
  • 11.2.16 SPT LABTECH
  • 11.2.17 BIOSERO, INC.

12 APPENDIX

• 12.1 DISCUSSION GUIDE
• 12.2 KNOWLEDGESTORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
• 12.3 CUSTOMIZATION OPTIONS
• 12.4 RELATED REPORTS
• 12.5 AUTHOR DETAILS